Yunnan Jianzhijia Health-Chain Co Ltd (605266) - Net Assets
Based on the latest financial reports, Yunnan Jianzhijia Health-Chain Co Ltd (605266) has net assets worth CN¥2.71 Billion CNY (≈ $396.15 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥9.39 Billion ≈ $1.37 Billion USD) and total liabilities (CN¥6.69 Billion ≈ $978.51 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 605266 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.71 Billion |
| % of Total Assets | 28.82% |
| Annual Growth Rate | 29.89% |
| 5-Year Change | 41.13% |
| 10-Year Change | 985.03% |
| Growth Volatility | 52.04 |
Yunnan Jianzhijia Health-Chain Co Ltd - Net Assets Trend (2014–2025)
This chart illustrates how Yunnan Jianzhijia Health-Chain Co Ltd's net assets have evolved over time, based on quarterly financial data. See Yunnan Jianzhijia Health-Chain Co Ltd (605266) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Yunnan Jianzhijia Health-Chain Co Ltd (2014–2025)
The table below shows the annual net assets of Yunnan Jianzhijia Health-Chain Co Ltd from 2014 to 2025. For live valuation and market cap data, see market value of Yunnan Jianzhijia Health-Chain Co Ltd.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥2.67 Billion ≈ $390.95 Million |
-3.92% |
| 2024-12-31 | CN¥2.78 Billion ≈ $406.88 Million |
-2.25% |
| 2023-12-31 | CN¥2.84 Billion ≈ $416.26 Million |
+11.15% |
| 2022-12-31 | CN¥2.56 Billion ≈ $374.49 Million |
+35.19% |
| 2021-12-31 | CN¥1.89 Billion ≈ $277.01 Million |
+11.24% |
| 2020-12-31 | CN¥1.70 Billion ≈ $249.01 Million |
+194.51% |
| 2019-12-31 | CN¥577.80 Million ≈ $84.55 Million |
+29.12% |
| 2018-12-31 | CN¥447.50 Million ≈ $65.48 Million |
+31.35% |
| 2017-12-31 | CN¥340.69 Million ≈ $49.85 Million |
+38.36% |
| 2016-12-31 | CN¥246.23 Million ≈ $36.03 Million |
+37.87% |
| 2015-12-31 | CN¥178.59 Million ≈ $26.13 Million |
+18.71% |
| 2014-12-31 | CN¥150.45 Million ≈ $22.02 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Yunnan Jianzhijia Health-Chain Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 28992.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.17 Billion | 43.65% |
| Other Components | CN¥1.51 Billion | 56.35% |
| Total Equity | CN¥2.67 Billion | 100.00% |
Yunnan Jianzhijia Health-Chain Co Ltd Competitors by Market Cap
The table below lists competitors of Yunnan Jianzhijia Health-Chain Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Zhejiang Yangfan New Materials Co Ltd
SHE:300637
|
$353.48 Million |
|
ANY Security Printing PLC
BUD:ANY
|
$353.66 Million |
|
Hyliion Holdings Corp.
NYSE MKT:HYLN
|
$353.71 Million |
|
Shandong Cynda Chemcial Co Ltd
SHG:603086
|
$353.77 Million |
|
Polisan Holding AS
IS:POLHO
|
$353.36 Million |
|
Brunel International NV
AS:BRNL
|
$353.34 Million |
|
Aclaris Therapeutics Inc
NASDAQ:ACRS
|
$353.21 Million |
|
Ferm. Casino Mun. Canne
PA:FCMC
|
$353.17 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Yunnan Jianzhijia Health-Chain Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,797,247,891 to 2,672,984,000, a change of -124,263,891 (-4.4%).
- Net income of 148,149,264 contributed positively to equity growth.
- Dividend payments of 242,901,725 reduced retained earnings.
- Other comprehensive income decreased equity by 121,948.
- Other factors decreased equity by 29,389,483.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥148.15 Million | +5.54% |
| Dividends Paid | CN¥242.90 Million | -9.09% |
| Other Comprehensive Income | CN¥-121.95K | -0.0% |
| Other Changes | CN¥-29.39 Million | -1.1% |
| Total Change | CN¥- | -4.44% |
Book Value vs Market Value Analysis
This analysis compares Yunnan Jianzhijia Health-Chain Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.90x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 10.35x to 0.90x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | CN¥1.51 | CN¥15.63 | x |
| 2015-12-31 | CN¥1.77 | CN¥15.63 | x |
| 2016-12-31 | CN¥2.44 | CN¥15.63 | x |
| 2017-12-31 | CN¥3.36 | CN¥15.63 | x |
| 2018-12-31 | CN¥4.38 | CN¥15.63 | x |
| 2019-12-31 | CN¥5.65 | CN¥15.63 | x |
| 2020-12-31 | CN¥14.94 | CN¥15.63 | x |
| 2021-12-31 | CN¥13.66 | CN¥15.63 | x |
| 2022-12-31 | CN¥20.56 | CN¥15.63 | x |
| 2023-12-31 | CN¥18.50 | CN¥15.63 | x |
| 2024-12-31 | CN¥18.12 | CN¥15.63 | x |
| 2025-12-31 | CN¥17.30 | CN¥15.63 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Yunnan Jianzhijia Health-Chain Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.54%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.66%
- • Asset Turnover: 0.91x
- • Equity Multiplier: 3.65x
- Recent ROE (5.54%) is below the historical average (16.87%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 11.05% | 1.04% | 1.65x | 6.42x | CN¥1.65 Million |
| 2015 | 9.64% | 0.97% | 1.77x | 5.60x | CN¥-668.31K |
| 2016 | 27.69% | 3.45% | 1.77x | 4.54x | CN¥45.29 Million |
| 2017 | 26.98% | 4.04% | 1.58x | 4.23x | CN¥59.72 Million |
| 2018 | 29.09% | 4.83% | 1.64x | 3.68x | CN¥87.69 Million |
| 2019 | 28.42% | 4.76% | 1.77x | 3.37x | CN¥108.96 Million |
| 2020 | 14.63% | 5.62% | 1.29x | 2.02x | CN¥79.43 Million |
| 2021 | 15.74% | 5.74% | 1.00x | 2.73x | CN¥109.55 Million |
| 2022 | 14.53% | 4.98% | 0.80x | 3.64x | CN¥116.71 Million |
| 2023 | 14.48% | 4.56% | 0.91x | 3.48x | CN¥128.30 Million |
| 2024 | 4.58% | 1.38% | 0.87x | 3.80x | CN¥-151.60 Million |
| 2025 | 5.54% | 1.66% | 0.91x | 3.65x | CN¥-119.15 Million |
Industry Comparison
This section compares Yunnan Jianzhijia Health-Chain Co Ltd's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $1,829,305,172
- Average return on equity (ROE) among peers: 8.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Yunnan Jianzhijia Health-Chain Co Ltd (605266) | CN¥2.71 Billion | 11.05% | 2.47x | $353.46 Million |
| Cachet Pharmaceutical Co Ltd (002462) | $1.30 Billion | 9.99% | 1.14x | $535.28 Million |
| Yunnan Hongxiang Yixintang (002727) | $810.77 Million | 22.52% | 0.88x | $917.76 Million |
| Luyan Pharma Co Ltd (002788) | $1.57 Billion | 8.34% | 2.28x | $621.39 Million |
| Ji Yao Holding Group Co Ltd (300108) | $-366.31 Million | 0.00% | 0.00x | $20.47 Million |
| ShuYu Civilian Pharmacy Corp. Ltd. (301017) | $2.27 Billion | 10.12% | 2.47x | $777.53 Million |
| Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) | $1.59 Billion | -15.22% | 2.98x | $278.33 Million |
| Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) | $2.16 Billion | 8.85% | 1.54x | $900.84 Million |
| Shanghai No1 Pharmacy Co Ltd (600833) | $749.32 Million | 9.15% | 0.86x | $316.33 Million |
| Dashenlin Pharm Grp Co Ltd (603233) | $4.33 Billion | 16.22% | 1.00x | $2.69 Billion |
| Laobaixing Pharmacy (603883) | $3.87 Billion | 13.13% | 1.56x | $1.31 Billion |
About Yunnan Jianzhijia Health-Chain Co Ltd
Jianzhijia Pharmaceutical Chain Group Co., Ltd. engages in the pharmaceutical retail business in China. The company offers pharmaceuticals, health foods, personal care products, household health products, convenience foods, and daily consumables through offline community professional pharmacies, convenience stores, community clinics, Chinese medicine clinics, and physical examination centers in b… Read more